The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Age and Gender Predict the Outcome of Treatment for Graves' Hyperthyroidism
Abstract
The response to treatment in Graves' hyperthyroidism is unpredictable, and factors postulated to predict outcome have not generally proved clinically useful or been widely adopted in clinical practice. We audited outcome in 536 patients with Graves' hyperthyroidism presenting consecutively to determine whether simple clinical features predict disease presentation and response to treatment. At presentation males had slightly more severe biochemical hyperthyroidism [free T4: males, 64.3 +/- 3.0 pmol/L (mean +/- SE); females, 61.3 +/- 1.7 (P = 0.45); free T3: males, 24.3 +/- 1.5 pmol/L; females, 21.0 +/- 0.6, (P = 0.04)]. Patients less than 40 yr at diagnosis had more severe hyperthyroidism than patients more than 40 yr old [free T4: <40 yr, 64.3 +/- 2.0; >40 yr, 56.7 +/- 2.3 (P = 0.02); free T3: <40 yr, 22.8 +/- 0.8; >40 yr, 19.0 +/- 0.9 (P = 0.003)]. Males had a lower remission rate than females after a course of antithyroid medication [19.6% vs. 40%; odds ratio, 0.37; 95% confidence interval (CI), 0.17-0.79; P < 0.01]. Similarly, patients aged less than 40 yr had a lower remission rate than older patients (32.6% vs. 47.8%; odds ratio, 0.53; 95% CI, 0.32-0.87; P = 0.01). One dose of radioiodine cured hyperthyroidism in fewer males than females (47% vs. 74%; P < 0.0001). Logistic regression analysis demonstrated male sex (odds ratio, 2.80; 95% CI, 1.31-5.98; P = 0.008), serum free T4 concentration at diagnosis (odds ratio, 1.02; 95% CI, 1.0-1.04; P = 0.01), and dose of radioiodine administered (odds ratio, 0.99; 95% CI, 0.99-1.00; P = 0.001) were contributing factors associated with failure to respond to a single dose of radioiodine. As males and younger patients are more likely to fail to respond to medical treatment, and male patients are likewise less likely to respond to a single dose of radioiodine, we suggest that those groups with low remission rates should be offered definitive treatment with radioiodine or surgery soon after presentation and that the value of higher initial doses of radioiodine in males be evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
TUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,674
Ingbar, S. H. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870060154035 · Cited by 1,743
Werner, S. C. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-1-203 · Cited by 466
WARTOFSKY, L., GLINOER, D., SOLOMON, B., NAGATAKI, S., LAGASSE, R., NAGAYAMA, Y., & IZUMI, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
The Management of Hyperthyroidism
Wood, A. J. J., & Franklyn, J. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302407 · Cited by 306
VITTI, P., RAGO, T., CHIOVATO, L., PALLINI, S., SANTINI, F., FIORE, E., ROCCHI, R., MARTINO, E., & PINCHERA, A. (1997) · Thyroid · doi:10.1089/thy.1997.7.369 · Cited by 293
Perros, P., Crombie, A. L., Matthews, J. N. S., & Kendall‐Taylor, P. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00516.x · Cited by 288
Franklyn, J. A., Maisonneuve, P., Sheppard, M., Betteridge, J., & Boyle, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12295-x · Cited by 243
Vanderpump, M. P. J., Ahlquist, J. A. O., Franklyn, J. A., & Clayton, R. N. (1996) · BMJ · doi:10.1136/bmj.313.7056.539 · Cited by 218
Graves' disease. Influence of age on clinical findings
Nordyke, R. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.3.626 · Cited by 174
Hypothyroidism as a Late Sequela in Patients with Graves' Disease Treated with Antithyroid Agents
Wood, L. C., & Ingbar, S. H. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109601 · Cited by 173
Schleusener, H., Schwander, J., Fischer, C., Holle, R., Holl, G., Badenhoop, K., Hensen, J., Finke, R., Bogner, U., Mayr, W. R., et al. (1989) · Acta Endocrinologica · doi:10.1530/acta.0.1200689 · Cited by 161
PREDICTION OF RELAPSE IN HYPERTHYROID GRAVES' DISEASE
McGregor, A. M., Smith, B. R., Hall, R., Petersen, M. M., Miller, M. A., & Dewar, P. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91551-2 · Cited by 153
Heward, J. M., Allahabadia, A., Daykin, J., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5137 · Cited by 140
Self-citationSex hormones, glucocorticoids and autoimmunity: facts and hypotheses.
da Silva, J. A. P. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.1.6 · Cited by 137
Hormonal Regulation of Immune Responses
Paavonen, T. (1994) · Annals of Medicine · doi:10.3109/07853899409147900 · Cited by 127
Success Rate of Radioiodine Therapy in Graves' Disease: The Influence of Thyrostatic Medication
Sabri, O., Zimny, M., Schulz, G., Schreckenberger, M., Reinartz, P., Willmes, K., & Buell, U. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5588 · Cited by 126
Glinoer, D., Hesch, D., Lagasse, R., & Laurberg, P. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.115s006 · Cited by 117
Benker, G., REINWEIN, D., Kahaly, G., Tegler, L., Alexander, W. D., Faßbinder, J., & Hirche, H. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00554.x · Cited by 108
Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement: Table 1
Gittoes, N. J. L., Miller, M. R., Daykin, J., Sheppard, M. C., & Franklyn, J. A. (1996) · BMJ · doi:10.1136/bmj.312.7029.484 · Cited by 90
Goitre size and outcome of medical treatment of Graves' disease
Laurberg, P., Buchholtz, P. E., Iversen, E., Jensen, S. E., & Weeke, J. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.1110039 · Cited by 86
Prediction of Outcome in Graves' Disease after Carbimazole Treatment
Weetman, A. P., Ratanachaiyavong, S., MIDDLETON, G. W., LOVE, W., John, R. M., OWEN, G. M., Darke, C., Lazarus, J. H., HALL, R., & McGregor, A. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a067969 · Cited by 55
Takamatsu, J., Kuma, K., & Mozai, T. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-980 · Cited by 48
Age‐Related Therapeutic Response to Antithyroid Drug in Patients with Hyperthyroid Graves' Disease
Yamada, T., Aizawa, T., Koizumi, Y., Komiya, I., Ichikawa, K., & Hashizume, K. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb04973.x · Cited by 47
Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism
Franklyn, J. A., Daykin, J., Holder, R. L., & Sheppard, M. C. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a069043 · Cited by 46
Factors influencing the outcome of thyrostatic drug therapy in Graves' disease
Winsa, B., Dahlberg, P. A., Jansson, R., Ågren, H., & Karlsson, F. A. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1220722 · Cited by 46
Hyperthyroidism in the Elderly
KAWABE, T., Komiya, I., Endo, T., Koizumi, Y., & Yamada, T. (1979) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1979.tb06438.x · Cited by 43
Aizawa, T., Ishihara, M., Hashizume, K., Takasu, N., & Yamada, T. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb07279.x · Cited by 33
Schleusener, H., Schwander, J., Holl, G., Badenhoop, K. W. J., Hensen, J., Finke, R., Schernthaner, G.-H., Mayr, W. R., & Kotulla, P. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.114s318 · Cited by 21
Martino, E., Pinchera, A., CAPIFERRI, R., Macchia, E., Sardano, G., Bartalena, L., Mazzanti, F., & Baschieri, L. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-3-543 · Cited by 20
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Brent, G. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801880 · Cited by 594
Bonnema, S. J., & Hegedüs, L. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 339
Metadata
- Authors
- Allahabadia, A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-03-01
- Volume
- 85
- Issue
- 3
- Pages
- 1038-1042
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2103675841
- Cited by
- 286
- References
- 31
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.